VIVUS, Inc.
(NASDAQ : VVUS)

( )
VVUS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.56%14.3614.2%$227.60m
SHPGShire PLC Sponsored ADR
1.64%143.160.4%$216.15m
PRGOPerrigo Co. Plc
1.30%78.596.4%$152.47m
MNKMallinckrodt Plc
2.77%37.1317.7%$118.19m
UTHRUnited Therapeutics Corporation
1.13%131.2813.9%$88.16m
JAZZJazz Pharmaceuticals Plc
2.89%146.742.2%$81.28m
ENDPEndo International Plc
-1.64%8.388.9%$71.09m
HZNPHorizon Pharma plc
-0.34%13.137.6%$65.29m
ALRAlere Inc.
0.22%49.552.7%$64.57m
PRXLPAREXEL International Corporation
0.07%87.737.9%$63.41m
ICPTIntercept Pharmaceuticals, Inc.
2.31%107.0922.1%$62.54m
MYOKMyoKardia, Inc.
1.27%43.803.0%$53.28m
NDRMNeuroDerm Ltd.
-0.13%38.603.6%$51.57m
PTLAPortola Pharmaceuticals, Inc.
0.70%55.958.9%$42.76m
ICLRICON Plc
2.46%107.894.2%$41.33m

Company Profile

VIVUS, Inc. operates as a biopharmaceutical company engages in the development and commercialization of novel therapeutic products. It offers the Qsymia for chronic weight management, as well as STENDRA and SPEDRA for erectile dysfunction. Its development also include Tacrolimus which is for the treatment of Pulmonary Arterial Hypertension. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.